NO20014119L - Medikament inneholdende et sulfopyranosylacylglycerolderivat - Google Patents

Medikament inneholdende et sulfopyranosylacylglycerolderivat

Info

Publication number
NO20014119L
NO20014119L NO20014119A NO20014119A NO20014119L NO 20014119 L NO20014119 L NO 20014119L NO 20014119 A NO20014119 A NO 20014119A NO 20014119 A NO20014119 A NO 20014119A NO 20014119 L NO20014119 L NO 20014119L
Authority
NO
Norway
Prior art keywords
medication containing
fatty acid
higher fatty
acyl residue
sulfopyranosylacylglycerol derivative
Prior art date
Application number
NO20014119A
Other languages
English (en)
Other versions
NO20014119D0 (no
NO329209B1 (no
Inventor
Takayuki Yamazaki
Fumio Sugawara
Keisuke Ohta
Kazuyoshi Masaki
Kotaro Nakayama
Kengo Sakaguchi
Noriyuki Sato
Hiroeki Sahara
Tatsuya Fujita
Original Assignee
Toyo Suisan Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Suisan Kaisha filed Critical Toyo Suisan Kaisha
Publication of NO20014119D0 publication Critical patent/NO20014119D0/no
Publication of NO20014119L publication Critical patent/NO20014119L/no
Publication of NO329209B1 publication Critical patent/NO329209B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)
NO20014119A 1999-02-26 2001-08-24 Farmasoytisk preparat inneholdende et sulfopyranosylacylglyserolderivat, slike forbindelser for anvendelse ved behandling av kreft, samt anvendelse av forbindelsene ved fremstilling av medikamenter NO329209B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5139799 1999-02-26
PCT/JP2000/000973 WO2000051622A1 (fr) 1999-02-26 2000-02-21 Medicaments contenant des derives du sulfopyranosylacylglycerol

Publications (3)

Publication Number Publication Date
NO20014119D0 NO20014119D0 (no) 2001-08-24
NO20014119L true NO20014119L (no) 2001-10-24
NO329209B1 NO329209B1 (no) 2010-09-13

Family

ID=12885820

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014119A NO329209B1 (no) 1999-02-26 2001-08-24 Farmasoytisk preparat inneholdende et sulfopyranosylacylglyserolderivat, slike forbindelser for anvendelse ved behandling av kreft, samt anvendelse av forbindelsene ved fremstilling av medikamenter

Country Status (13)

Country Link
US (3) US6770629B2 (no)
EP (1) EP1172107B1 (no)
JP (1) JP3771445B2 (no)
KR (1) KR100528874B1 (no)
CN (1) CN1151795C (no)
AT (1) ATE348623T1 (no)
AU (1) AU764246B2 (no)
BR (1) BR0008516A (no)
CA (1) CA2365359C (no)
DE (1) DE60032470T2 (no)
EA (1) EA003094B1 (no)
NO (1) NO329209B1 (no)
WO (1) WO2000051622A1 (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3851461B2 (ja) 1998-09-04 2006-11-29 東洋水産株式会社 ピラノシドおよびその製造方法
CA2365359C (en) * 1999-02-26 2007-09-18 Toyo Suisan Kaisha, Ltd. Medicaments containing a sulfopyranosylglycerol derivative
DE60003795T2 (de) 1999-02-26 2004-06-17 Toyo Suisan Kaisha, Ltd. Sulfofukosylacylglycerin-derivate und ihre anwendung als medikamente
WO2003006028A1 (fr) * 2001-07-09 2003-01-23 Toyo Suisan Kaisha, Ltd. Nouveaux immunosuppresseurs
FR2840318B1 (fr) * 2002-05-29 2004-12-03 Quoc Kiet Pham Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih
NO20025738D0 (no) * 2002-11-29 2002-11-29 Amersham Health As Metode
EP1666024A4 (en) * 2003-08-29 2009-11-25 Sato Pharma PREPARATION FOR RECTAL ADMINISTRATION
KR100832167B1 (ko) * 2004-06-24 2008-05-23 토요 수이산 가부시키가이샤 방사선치료 증감제
JP4435861B2 (ja) * 2007-07-20 2010-03-24 東洋水産株式会社 新規なスルホン酸化糖誘導体およびその医薬としての使用
KR20110101200A (ko) * 2009-01-16 2011-09-15 토요 수이산 가부시키가이샤 종양 체류성을 갖는 화합물
EP2536414B1 (en) 2010-02-18 2016-07-13 INSERM (Institut National de la Santé et de la Recherche Médicale) Method for preventing cancer metastasis
EP2768425B1 (en) 2011-10-17 2018-11-14 University of Utah Research Foundation Methods and devices for connecting nerves
US10842494B2 (en) 2011-10-17 2020-11-24 University Of Utah Research Foundation Methods and devices for connecting nerves
DE102015011780A1 (de) * 2015-09-16 2017-03-16 Hochschule Anhalt Neue Glutaminylcyclase-lnhibitoren
JP6903273B1 (ja) 2020-09-25 2021-07-14 株式会社エム・ティー・スリー 化合物又はその塩、及び放射性増感剤
CN113476610A (zh) * 2021-08-13 2021-10-08 云南中医药大学 甘油衍生物与抗真菌药物组成的抗真菌药物组合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55130996A (en) * 1979-03-30 1980-10-11 Rikagaku Kenkyusho Novel maltose derivative and its preparation
JPS6040159A (ja) * 1983-08-15 1985-03-02 Nissan Motor Co Ltd 強化形防錆ワツクス
JP2872695B2 (ja) * 1989-07-19 1999-03-17 エーザイ株式会社 腎炎の治療剤
JP2872694B2 (ja) * 1989-07-19 1999-03-17 エーザイ株式会社 血管内血液凝固症候群の治療剤
JPH0366603A (ja) * 1989-08-04 1991-03-22 Mikio Nakanishi 界面活性剤を用いる赤潮プランクトンの駆除方法
DK0486536T3 (da) * 1989-08-15 1995-04-10 Us Health Antivirale midler midler indeholdende sulfoquinovosylglycerolderivater og analoger deraf
JPH03246203A (ja) * 1990-02-20 1991-11-01 Mikio Nakanishi 赤潮プランクトンの駆除方法
US5695752A (en) * 1992-09-11 1997-12-09 The Regents Of The University Of California Treating inflammation via the administration of specific sulfatase enzymes and/or sulfation inhibitor
WO1995013819A1 (en) * 1993-11-19 1995-05-26 The Regents Of The University Of California Sulfated ligands for l-selectin and methods of preventing sulfate addition
US5783693A (en) * 1993-11-19 1998-07-21 The Regents Of The University Of California Methods for synthesizing sulfated disaccharide inhibitors of selectins
JPH07149786A (ja) 1993-11-26 1995-06-13 Sagami Chem Res Center グリセロ糖脂質及び発癌プロモーター阻害剤
JPH07242691A (ja) 1994-01-17 1995-09-19 Sankyo Co Ltd １位にカルボキシメチレン基を有する４−ホスホノグルコサミン類
JPH09268198A (ja) 1996-04-02 1997-10-14 Sanei Touka Kk ＤＮＡポリメラーゼα阻害物質及びその製造方法
SE9601677D0 (sv) * 1996-05-02 1996-05-02 Scotia Lipidteknik Ab New use
JP4454051B2 (ja) * 1997-01-24 2010-04-21 東洋水産株式会社 新規な糖脂質、その製造方法及びその用途
JP3851461B2 (ja) 1998-09-04 2006-11-29 東洋水産株式会社 ピラノシドおよびその製造方法
CA2365359C (en) * 1999-02-26 2007-09-18 Toyo Suisan Kaisha, Ltd. Medicaments containing a sulfopyranosylglycerol derivative
US6518410B2 (en) * 1999-02-26 2003-02-11 Toyo Suisan Kaisha, Ltd. Sulfoquinovosylacylglycerol derivative, and use thereof as medicaments
EP1164139B1 (en) 1999-02-26 2003-07-09 Toyo Suisan Kaisha, Ltd. Novel sulforhamnosylacylglycerol derivatives and use thereof as medicaments
DE60003795T2 (de) 1999-02-26 2004-06-17 Toyo Suisan Kaisha, Ltd. Sulfofukosylacylglycerin-derivate und ihre anwendung als medikamente
PT1172108E (pt) 1999-03-11 2005-02-28 Toyo Suisan Kaisha Utilizacao de derivados de sulfoquinovosildiacilglicerol como imunossupressores

Also Published As

Publication number Publication date
JP3771445B2 (ja) 2006-04-26
NO20014119D0 (no) 2001-08-24
US20040067893A1 (en) 2004-04-08
EP1172107A4 (en) 2003-07-23
US6770629B2 (en) 2004-08-03
CN1151795C (zh) 2004-06-02
DE60032470D1 (de) 2007-02-01
WO2000051622A1 (fr) 2000-09-08
KR100528874B1 (ko) 2005-11-15
AU764246B2 (en) 2003-08-14
BR0008516A (pt) 2001-11-06
ATE348623T1 (de) 2007-01-15
US20060252703A1 (en) 2006-11-09
CA2365359C (en) 2007-09-18
CN1341025A (zh) 2002-03-20
US7148200B2 (en) 2006-12-12
CA2365359A1 (en) 2000-09-08
EP1172107A1 (en) 2002-01-16
KR20010114211A (ko) 2001-12-31
AU2575500A (en) 2000-09-21
US20020028776A1 (en) 2002-03-07
EP1172107B1 (en) 2006-12-20
US7378398B2 (en) 2008-05-27
DE60032470T2 (de) 2007-10-11
EA003094B1 (ru) 2002-12-26
NO329209B1 (no) 2010-09-13
EA200100916A1 (ru) 2002-02-28

Similar Documents

Publication Publication Date Title
NO20014119L (no) Medikament inneholdende et sulfopyranosylacylglycerolderivat
FI950309A (fi) Proliiniamidijohdannaisia
ATE109149T1 (de) 3-pyrrolidinylthio-1-azabicyclo(3.2.0>-hept-2-e - 2-carbonsäureverbindungen.
ATE358484T1 (de) Antidiabetische medikamente
DE69623497D1 (de) 1-methylcarbapenem-derivate
NO20014382L (no) Nye immunoundertrykkende middel
ES2180972T3 (es) Composicion contra el helicobacter pilori que contiene derivados de 1-metilcarbapenem como ingrediente activo.
BRPI0511824A (pt) radiossensibilizador
TW280810B (no)
CA2452530A1 (en) Novel immunosuppressive agent

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees